Abstruct To evaluate whether cyclooxygenase constructor substances can nnparr mtnc oxide-mediated vasodrlatron m essentral hypertension, in seven normotensive sublects (43 324 1 years, BP, 117-+6/81t2 mm Hg) and seven essential hypertensave patients (47 l-t5 2 years, BP, 151C8/98+4 mm Hg) we studied forearm blood flow (strain-gauge plethysmography) modrficatrons induced by mtrabrachral acetylcholme (0.15, Cl 45, 1 5, 4 5, 15 pg 100 mL-' mm-') m basal condrtrons, durmg mfuston of NC-monomethyl-L-argnnne (L-NMMA, 100 pg 100 mL-' mn-'), a mtnc oxide synthase mhrbrtor, or mdomethacm (50 /-lg 100 mL-' mm-'), a cyclooxygenase mhrbrtor, or srmultaneous mdomethacm and L-NMMA In normotensrves, vasodrlatron to acetylcholme was blunted by L-NMMA (maximum flow increase' 671+64% and 386+42%, respectrvely, P< Ol), and this effect was unchanged by mdomethacm In contrast, m hypertensrve patients, vasoddatron to acetylcholme (maxrmum llow increase 458233%) was unchanged by L-NMMA Indomethacm stgmficantly (P< 01) increased the response to acetylcholme (maximum flow increase 635t53%) and restored the mhrbrtory effect of L-NMMA (maximum flow Increase 445&36%, P< 01 versus mdomethacm alone) In an adJunctive seven normotensaves (51 4t4 2 years, BP, 114+5/79+3 mm Hg) and seven essential hypertenstves (53 247 6 years, BP, 153?9/100&3 mm Hg) we repeated the same protocol by replacmg L-NMMA with L-argmme (200 pg 100 mL-r mn-'), the substrate for NO synthase In normotensrves, vasodrlatron to acetylchohne was mcreased by L-argmme (maximum flow Increase 539~48% and 806?61%, respectrvely) and this effect was unchanged by mdomethacm In hypertensive patrents, vasodrlatron to acetylchohne (maximum flow Increase 339532%) was unchanged by L-argnnne but was srgnrficantly (P< 01) increased by mdomethacm (maxrmum flow increase 592238%)
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Moreover, mdomethacm restored the facrlrtatory effect of L-argmme (maxrmum flow increase 804?56%, P< 01 versus mdomethacm alone) Therefore, cyclooxygenase mhrbrtron restores mtrrc oxide-mediated vasodrlatron m essential hypertension, suggestmg that cyclooxygenase-dependent substances can rmparr mtnc oxide productron (Hypertenszon. 1997; 29[part 21: 274-279.) Key Words l hypertension l endothelmm l mtrrc oxtde l endothehum-derived factors l mdomethacm E ndothelmm plays a major role m the modulation of vascular tone through the productton and release of different relaxing and constricting factors acting on the underlying smooth muscle cells r The major endothehum-derived relaxing factor is NO,* a labile substance derived from L-argmine by the activity of the enzyme NO synthase.3 Importantly, this process can be competitively mhtbited by r.-argmme analogues such as L-NMMA.4.5 Moreover, EDCF are mainly cyclooxygenase-dependent prostanoids (thromboxane A2 and prostaglandm H2)6-9 or superoxrde anions 10
The crucial role of endothehal cells in vascular homeostasis is further emphasized by the evidence of tmpaired endotheltum-dependent responses m cardtovascular disease such as essential hypertension Thus, m essential hypertensive patients, vasodtlatron to endothelmm-dependent agonists (mamly acetylcholme or bradykmln) 1s reduced compared with normotenstve control subJects.rr-I5 This abnormality 1s caused by a defect in NO activity since both L-arginme and L-NMMA, which in normal conditions can increase or reduce the response to acetylcholme, respectively, are meffectrve m hypertensive patients. 16-18 Moreover, mdomethacm, a cyclooxygenase mhtbrtor, can potentrate the vasodrlatron to acetylcholme m hypertensive patients but not in normotensive control subJects, inFrom I Clnnca Medrca, Umversrty of Prsa, Italy Correspondence to Stefano Tadder, MD, I Clmrca Medrca, Unrversrty of Prsa, Vta Roma, 67, 56100 Prsa, Italy 0 1997 Amerrcan Heart Assocratron, Inc drcatmg the synthesis of cyclooxygenase-dependent EDCF 13 Thus taken together these observations suggest that m essential hypertension endothelial dysfunction 1s caused by the simultaneous presence of a defect m the L-argmme-NO pathway and productton of cyclooxygenase-dependent EDCF However, the possrbthty exists that these alterations are not abnormahttes which are parallelly associated with hypertensive disease, but, as demonstrated m certain animal models, EDCF can negatively Interact with the L-argmme pathway, causing NO destruction 1~ Thus the present study was designed to evaluate whether cyclooxygenasedependent EDCF can tmparr the L-argmme-NO pathway m essential hypertenstve patients. Spectfically, the mvestigatton focused on assessing whether cyclooxygenase blockade can restore the facrhtatmg or mhtbrting effect of L-argmme and L-NMMA, respectively, on the vasodilating response to acetylcholme m essential hypertensive patients
Patients

Methods
The study populatron mcluded 14 normotensrve control subjects and 14 matched essentral hypertensive patients Subjects wtth hypercholesterolemra (total cholesterol greater than 5 2 mmol/L), diabetes melhtus, cardiac and/or cerebral rschemrc vascular disease, impaired renal function and other major pathologies were excluded from the study Moreover, subjects or patrents smoking more than five cigarettes per day and/or consummg more than 60 g of ethanol (correspondmg to half a liter of wme) per day were excluded from the study In accordance with mstrtutronal gurdelmes, all patients were aware of the mvestrgatronal Selected Abbreviations and Acronyms BP = blood pressure EDCF = endothehum-derived contractmg factor(s) FBF = forearm blood flow L-NMMA = NG-monomethyl-L-argmme NO = nitric oxide NS = not slgmficant I nature of the study and gave wntten consent to it Any pharmacological treatment was chscontmued for at least 2 weeks before perforrnmg the study SubJects, defined as normal accordmg to the absence of famthal history of essential hypertension and BP below 140/90 mm Hg, were characterized by mean age of 47 624 3 years and BP values of 115 656 l/80 352 1 mm Hg Essential hypertensive patients were recruited from among the newly diagnosed cases m our outpatient chnlc If they reported the presence of positive family history of essential hypertension, whenever supine arterial BP (after 10 minutes of rest) measured by mercury sphygmomanometer three times at l-week intervals was conslstently found greater than 140/90 mm Hg Secondary forms of hypertension were excluded by routine diagnostic procedures Mean age was 50 6t6 6 years and BP values were 152 528 71 99 2k3.6 mm Hg Since the patients were newly diagnosed cases, they were never treated and the known history of hypertension had lasted 2 1 +O 4 years The demographlc and chmcal characteristics of the two groups are shown m the Table   Experimental Procedure All studies were performed at 08 00 AM after overnight fast with the SubJects lymg supine in a quiet air-condltloned room (22°C to 24°C) A polyethylene cannula (21 gauge, Abbot) was inserted mto the brachlal artery under local anesthesia (2% hdocame) and connected through stopcocks to a pressure transducer (Model MS20, Electromedics) for systemic mean BP (one third pulse pressurefdlastohc pressure) and heart rate momtormg (Model VSMl, Physiocontrol) and for mtra-arterial mfuslons FBF was measured m both forearms (experimental and contralateral forearm) by stram-gauge venous plethysmography (LOOSCO, GL LOOS) z0 Circulation to the hand was excluded 1 minute before each sampling or FBF measurement by mflatmg a pediatric cuff around the wrist at suprasystohc BP Details concerning the sensitivity and reproduciblhty of the method as performed m our laboratory have already been published 19
Forearm volume was measured according to the water chsplacement method and drug infusion rates were normahzed to 100 mL tissue by alteration of the drug concentration m the solvent while the pump speed of infusion was kept constant Drugs were infused at systemically ineffective rates through separate ports via three-way stopcocks Experimental Design Endothehum-dependent vasodilation was estimated by performing a dose-response curve to mtra-arterial acetylchohnez* (cumulative increase of the infusion rates 0 15,0.45, 1 5,4 5, 15 lg/lOO mL forearm tissue per minute, for 5 minutes at each dose) while endothehum-independent vasochlatlon was assessed with a dose-response curve to mtra-arterial sodium mtroprusside, a &-rect smooth muscle cell relaxant compound23 (cumulative mcrease by 1, 2, and 4 kg/100 mL forearm tissue per minute, for 5 minutes at each dose) These rates were selected to induce vasochlation comparable to that obtained with acetylchohne Effect of Cyclooxygenase Inhibition on Response to Acetylcholine in the Presence of L-NMMA In seven normotensive subjects and seven essential hypertensive patients, after sodium mtroprusside infusion, the dose-response curve to mtra-arterial acetylchohne was performed according to the followmg design during sahne (0.2 mL/mm), m the presence of mtra-arterial L-NMMA (100 pg/lOO mL forearm tissue per minute, started 10 mmutes before acetylchohne and continued throughout), m the presence of mtra-arterial mdomethacm (50 pg/lOO mL forearm tissue per minute, started 10 minutes before acetylchohne and continued throughout), and finally m the presence of simultaneous infusion of L-NMMA and mdomethacm
Effect of Cyclooxygenase Inhibition on Response to Acetylcholine in the Presence of L-Arginine
In an adjunctive seven normotensive subjects and seven essential hypertensive patients, the same previously described protocol was performed by replacing L-NMMA with L-argmme infused mtrabraclnally at 200 pg/lOO mL forearm tissue per minute Thirty minutes of washout was allowed between each dose-response curve m the presence of saline, while 60 minutes was allowed when L-argmme or mdomethacm was infused simultaneously
Data Analysis
Since arterial pressure did not significantly change during the study, all data were analyzed m terms of FBF, FBF increments were taken as evidence of local vasochlatlon Differences between two means were compared by paired or unpaired In the overall population, vasochlatlon to acetylchohne was significantly (P< 01) blunted m essential hypertensive patients (FBF rose from 3.420.5 to a maximum of 17 123 2 mWlO0 mL forearm tissue per minute with the highest dose) compared with normotenslve control subjects (FBF rose from 3.420.4 to a maximum of 23.925 4 mL/lOO mL forearm tissue per minute with the highest dose) (Fig 1) . In contrast, the vasodilatmg effect of the endothelmm independent vasochlator sodium mtroprusside was similar m normotensive subjects and essential hypertensive patients (FBF rose from 3.620 4 to a maximum of 24 122.9 mWlO0 mL forearm tissue per minute with the highest dose and from 3 520 4 to a maximum of 23 3k3.1 mL/lOO mL forearm tissue per minute, respectively, NS) (Fig 1) Effect of Cyclooxygenase Inhibition on Response to Acetylcholine in the Presence of L-NMMA In this group of normotensive control subjects, L-NMMA infusion caused a decrement m basal FBF (from 3 420.4 to 1 9-+0 2 mL/lOO mL forearm tissue per minute; P< 01) and significantly blunted the vasodllatmg effect of acetylchohne (saline: from 3 4+0 4 to 26.225.6 mL/lOO mL forearm tissue per minute, L-NMMA from 1 9+-O 2 to 8.322.1 mL/lOO mL forearm tissue per minute, P<.Ol versus acetylchohne alone) (Ag 2) Again mdomethacm chd not change either basal FBF (from 3 4-t-O 4 to 3.420.4 mL/lOO mL forearm tissue per minute), the response to acetylchohne (from 3 4+0 4 to 26.825.4 mL/lOO mL forearm tissue per minute), or the mlubitmg effect of L-NMMA on vasodilation to acetylchohne (from 1.9kO.2 to 8.322.5 mWlO0 mL forearm tissue per minute) (Fig 2) 3o 1 FBF In the essential hypertensive patients, L-NMMA mfuSian caused a decrement m basal FBF (from 3 2&O 6 to 2 3kO.5 mL/lOO mL forearm tissue per minute, P-C 01) which was significantly smaller than that observed m normotensive control SubJects (percent FBF decrease 44% versus 28%, respectively, P< 01) However, the response to acetylchohne (from 3.2t0.5 to 17 724 2 mWlO0 mL forearm tissue per minute) was not changed by L-NMMA (from 2 3kO.5 to 12 523 2 mWlO0 mL forearm tissue per minute, NS versus saline) (Fig 2) . Indomethacm infusion chd not change basal FBF (from 3 1 +O 4 to 3 It0 6 mWlO0 mL forearm tissue per minute) Nevertheless, the cyclooxygenase mhlbitor increased the response to acetylcholine (from 3.1-+0 4 to 22 023 3 mL/ 100 mL forearm tissue per minute, P< 01 versus acetylcholine during saline) (Fig 2) . Finally, when the effect of L-NMMA was tested m the presence of mdomethacm, the NO synthase mhibitor blunted the vasochlatmg response to acetylchohne (from 2 3tO 5 to 12 5 +3 7 mL/lOO mL forearm tissue per minute, P< 01 versus acetylchohne during mdomethacm alone) (Fig 2) In both normotensive subjects and essential hypertensive patients contralateral FBF did not significantly change during the whole study (data not shown).
Effect of Cyclooxygenase Inhibition on Response to Acetylcholine in the Presence of L-Arginine
In this group of normotensive control SubJects, acetylcholine-dependent vasodllatlon (from 3.520 5 to 22.3 +3 3 mL/lOO mL forearm tissue per minute) was significantly (P< 01) increased by the simultaneous infusion of L-argmme (from 3 720.3 to 33.525 8 mWlO0 mL forearm tissue per minute) (Fig 3) . Indomethacm admmlstratlon faded to affect either the response to acetylcholme infused alone (from 3.6kO.5 to 22 5t3.5 mL/lOO mL forearm tissue per mmute, P=NS versus acetylcholme during saline) or the faclhtatmg effect of L-argmine on acetylcholine-induced vasodllatlon (FBF from 3.5kO.5 to 31.9+5 2 mL/lOO mL forearm tissue per minute, P=NS versus acetylcholine during salme+indomethacm) (Ag 2) Of note 1s that both L-argmme and mdomethacin, when mfused alone, did not change basal FBF (data not shown) Different results were obtained m essential hypertensive patients Again acetylcholme infusion caused a dose-dependent vasodllatlon (from 3.6kO.5 to 16.4k2.9 mL/lOO mL forearm tissue per minute) which was statlstlcally lower (P<.Ol) than that observed in normotenslve control SubJects L-Argmme administration changed neither basal FBF ( from 3.6t0.5 to 3 740 4 mL/lOO mL forearm tissue per minute) or the vasodilatmg effect of acetylcholme (from 3 7+0.4 to 16 523.1 mWlO0 mL forearm tissue per minute, NS versus saline) (Fig 3) . Indomethacm did not change basal FBF (from 3 3rt0.5 to 3.420.4 mL/lOO mL forearm tissue per minute), but slgmficantly increased the response to acetylcholine (from 3.450.4 to 23.6k3.4 mL/ 100 mL forearm tissue per minute, P< 01 versus saline) (Fig 2) . It is worth noting, finally, that when L-argmme was coinfused with mdomethacm the vasodilatmg effect of acetylcholme was further increased (from 3.4~0.5 to 31.124.1 mL/lOO mL forearm tissue per minute, P<.Ol versus acetylcholme in the presence of mdomethacm) 0% 3).
In both normotenslve subjects and essential hypertensive patients contralateral FBF did not significantly change during the whole study (data not shown).
Discussion
Essential hypertension is characterized by endothehal dysfunctlon.11-18 This alteration is further confirmed m the present study since the response to acetylchohne, an endothelmm-dependent vasodllator,'JV2* but not to sodmm mtroprusside, a direct smooth muscle cell relaxant,*3 was blunted m essential hypertensive patients compared with matched normotenslve control subjects The mechamsms responsible for the impaired endothehum-dependent vasodilatlon include an alteration in the L-argimne-NO pathway and production of cyclooxygenase-dependent EDCF. That these mechanisms can operate in essential hypertensive patients 1s confirmed by the present results. Thus, m agreement with previous observations, 16 admmlstratlon of L-argmme, the substrate for NO synthase,3 can increase the vasodllating effect of acetylcholine m normotenslve SubJects while the amino acid is ineffective in essential hypertensive patients. Moreover, L-NMMA, an antagonist for NO synthase,4J can blunt the response to acetylchohne m control SubJects, but not in hypertensive patients.15 Taken together these results clearly confirm the presence of a defect m the endothelium-derived NO system m essential hypertension, Since neither activation nor mhlbltlon of the NO pathway can lead to modifications of the vascular response to the endothelium-dependent vasodilator. It 1s important to observe that the lack of effect of these compounds on acetylchohne-induced vasodilatlon 1s not linked to insufficient infusion rates of either L-argmme or L-NMMA, as already demonstrated by previous evidence obtained in similar experimental condltlons.16J7
Moreover, this abnormality does not totally account for the Impaired vasodllatlon to acetylcholme observed in essential hypertension. Thus m hypertensive patients, but not in normotenslve subjects, mdomethacm increased the response to the endothelium-dependent vasodilator, confirming that, m agreement with previous evidence, 13 the production of cyclooxygenase derlvatlves can curtail endothelial responses m essential hypertension It 1s worth noting that for the first time the alteration m the endothelium-derived NO system and production of cyclooxygenase-dependent EDCF has been demonstrated m the same Hypertension Vol29, No 1, Part 2 January 1997 patients, supporting the possibility that these endothehal alterations coextst m essential hypertension.
However, the mam finding of the present study is the demonstration that m essential hypertensive patients cyclooxygenase mhtbmon by mdomethacm administration restores the potentiatmg and mhibitmg effect of L-argmme and L-NMMA, respectively, on acetylcholme-induced vasodilatton. In contrast, in normotenslve control SubJects, mdomethacin does not change the effect of L-argmme and L-NMMA on endothelium-dependent vasodilation to acetylcholme. Taken together these findings suggest that m essential hypertension, cyclooxygenase activity causes endothehal dysfunction by producing cyclooxygenase-dependent substances which, at least partially, can inactivate the L-argmine-NO system. There is experimental evidence indicating that m vessels from hypertensive animals a close relationship exists between the L-argmme-NO pathway and cyclooxygenase activity Thus in primary hypertension, cyclooxygenase activity is increased to produce not only vasoconstrtctor prostanotds,"-9324 but also superoxide anions, which cause NO breakdown 10.*5,*6 Moreover, it has been demonstrated in canme basilar arteries that an increased production of superoxtde anions can destroy NO produced by the acttvtty of the L-arginine pathway, thus causing full expression of vasoconstrictor prostanolds 25 This negative interaction between the NO system and cyclooxygenase activity could be a likely explanation for the impaired endothelmm-dependent vasodilation, which is characteristic of essential hypertensive patients Therefore, m our experimental condttions, in essential hypertensive patients the stimulation of endothehal cells could cause the activatton of two parallel pathways mvolvmg both NO synthase and cyclooxygenase. Cyclooxygenase activity could lead to the production of NOmacttvatmg substances (endoperoxidesv superoxtde anions?), thus explammg the absence of effects of L-argmme and L-NMMA on vasodtlatton to acetylcholme When cyclooxygenase is blocked by mdomethacm and NO breakdown no longer occurs or 1s at least decreased, it is therefore possible to demonstrate the acttvtty of L-arginine and L-NMMA as observed m normotensive control SubJects
The relationship between cyclooxygenase-dependent EDCF and primary hypertension is of interest It must be noted that these substances, while causing endothelial dysfunctions, do not seem to contribute to an increase m BP values. Thus, m the spontaneously hypertensive rat,*7 treatment by ifetroban, a thromboxane A,/prostaglandm endoperoxide-receptor blocker, normalized endothehumdependent relaxations to acetylcholme in isolated segments of aorta but produced no reduction m BP values. In agreement with experimental data, m human hypertension the acute admmistration of ndogrel, a combined thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, dtd not lower BP values m essential hypertensive patients.28 In addition, the lack of relationship between cyclooxygenase-dependent EDCF and BP values m humans is further confirmed by recent evidence mdicatmg that productton of such substances seem to be mainly relating to the aging process.29 Thus m normotensive subjects tt 1s possible to detect productton of EDCF when aging increases over 60 years, and this phenomenon is anticipated in essential hypertensive patients (starting from the fourth decade of life) However, it 1s worth noting that m young essential hypertensive patients production of cyclooxygenase-dependent EDCF does not seem to occur Therefore, the dissoctation between EDCF production and elevated BP values underlines the possibthty that EDCF do not participate m the development of hypertenston However, tt 1s well documented that whatever 1s the nature of EDCF (endoperoxide or superoxtde anions), they can increase vascular tone and stimulate platelet aggregation or smooth muscle cell proliferation by direct mechanisms or by mducmg NO breakdown.30 It 1s therefore concelvable that EDCF productton, although not important as a causal mechanism responstble for the development of hypertension, probably plays a role m the vascular damage associated with aging and hypertension itself.
As regards the important issue of the relationship between the duration of essential hypertension and EDCF production, no data are available to understand whether the degree of synthesis of these substances is m some way dependent on the length of the hypertensive process In the present study, unfortunately the recruited hypertensive population shows a quite short duration of hypertension and no conclusion can be drawn Finally, tt is worth noting that these endothehal mechanisms operate mainly when endothehal cells are sttmulated by acetylcholme Thus, m agreement with previous observations, neither L-argmmei6 nor mdomethacm13 (nor the combmatton of both compounds) can influence basal blood flow m either normotensive sublects or essential hypertensive patients In contrast, L-NMMA mfuston can decrease basal FBF, confirming that NO 1s basally released m human vasculature5 and this mechanism is defective m essential hypertension since, as previously demonstrated, '7 18 L-NMMA-induced vasoconstrtctlon 1s blunted m hypertensive patients compared with control subjects However, the simultaneous mfusion of mdomethacm with L-NMMA does not change the vasoconstrictor effect of the NO synthase mhtbttor suggestmg that cyclooxygenase activity does not participate m NO-mediated local regulation of basal flow.
In conclusion, the present results indicate that endotheha1 dysfunction which is characteristic of essential hypertension is determined by the simultaneous presence of an alteration m the L-argmme-NO pathway and production of cyclooxygenase dertvatlves These alterations do not seem to be independent smce m essential hypertensive patients, but not m normotensive control subjects, the dysfunctioning NO system seems to be restored or at least improved by cyclooxygenase blockade Which cyclooxygenase-dependent substances could be responsible for mhlbmon of the L-argmme NO pathway is, at the present time, under mvesttgatton 
